Article Details
Retrieved on: 2024-07-04 13:01:37
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Per the latest agreement, GSK will acquire global rights to develop and commercialize mRNA-based vaccine candidates for treating influenza and COVID- ...
Article found on: www.zacks.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here